Back

Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular and pulmonary Pulmonary Hypertension HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Marialucia Telesca

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

1 More presentation in this session

Presentation thumbnail
Glial-fibrillary acidic protein expressing valve interstitial cells and their role in valvular homeostasis promoting valvular heart disease as a reversible cause of heart failure
Doctor F. Schlotter (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in valvular and pulmonary

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Therapeutic modulation of the lung microenvironment in obesity-induced heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)
thumbnail
Congress Presentation
Epigenetic editing of BET proteins restores autophagy and cardiac function in cardiometabolic heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources